The University of Texas System

Microdose Therapeutx, Inc.

Rein Therapeutics, Inc.

Other

The Dow Chemical Company

Safe Flight Corporation

Alan B Watts

Robert O Williams, Iii

Keith P Johnston

Joshua Engstrom

Jasmine Rowe

True L Rogers

Jason T McConville

Robert Talbert

Jay I Peters

Prapasri Sinswat

John Joseph Koleng, Jr

Robert Owen Cook

Dale Christensen

Michael J Martin

Sawittree Sahakijpijarn

Yajie Zhang

Jay Peters

Iii Williams Robert O

Sreerama Shetty

Robert Williams

Jason T Mcconville

Jasmine Tam

Robert O Iii Williams

Simone Raffa Carvalho

Prapasri Sinwat

Provided herein are compositions comprising caveolin-1 (Cav-1) peptides. Further provided are methods of using the Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.

Dry powder formulation of caveolin-1 peptides and methods of use thereof

The present invention includes compositions and methods for treating and delivering medicinal formulations using an inhaler. The composition includes a space filled flocculated suspension having one or more flocculated particles of one or more active agents and a hydrofluoroalkane propellant. A portion of the one or more flocculated particles is templated by the formation of hydrofluoroalkane droplets upon atomization and the templated floc compacts upon the evaporation of the hydrofluoroalkane propellant to form a porous particle for deep lung delivery.

Templated open flocs of anisotropic particles for enhanced pulmonary delivery

The present invention includes compositions and methods for making and using a rapid dissolving, high potency, substantially amorphous nanostructured aggregate for pulmonary delivery of tacrolimus and a stabilizer matrix comprising, optionally, a polymeric or non-polymeric surfactant, a polymeric or non-polymeric saccharide or both, wherein the aggregate comprises a surface area greater than 5 m/g as measured by BET analysis and exhibiting supersaturation for at least 0.5 hours when 11-15-times the aqueous crystalline solubility of tacrolimus is added to simulated lung fluid.

Methods for making compositions for pulmonary administration

Compositions and methods of making brittle-matrix particles through blister pack freezing

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

Administration of Oxybutynin directly to a patient's lungs for treating urinary incontinence, respiratory disease or IBD.

Methods and compositions for administration of oxybutynin

An aircraft navigational facilitation system (20) and method of use thereof operates in conjunction with conventional apparatus which provides aircraft current situational information. The system includes a memory (22) for storing runway and landing information for each of a plurality runways. An input device, such as a keyboard (24), is provided for selecting a destination runway. The system further includes a video display device (28) which simulates the view from a cockpit of the aircraft, with the view including the destination runway. The video display device is driven by a processor (26) which uses the current situational information and the runway information for periodically generating display signals for the video display device. The display signals cause the video display to provide an updated and scaled simulated three dimensional view of a perimeter of the destination runway from a perspective of the cockpit of the aircraft. The video display device also provides further information including runway identification information, runway centerline, and an indication of a projected touch down point of the aircraft relative to the perimeter of the destination runway.

Aircraft landing guidance system and method

Growing community of inventors

Plainsboro, NJ, United States of America

Alan B Watts